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Secondary HIV self-test distribution increases male partner 
testing
There is established evidence that men are less likely 
than women to engage with HIV services; the latest 
global estimates show that, compared with women, 
1 million more men living with HIV do not know their 
status, 1·8 million know their status but are not on 
treatment, and 1·6 million are not virally suppressed.1 
Elimination of HIV requires concerted efforts to 
ensure that men are not left behind. Male partners 
of pregnant women are particularly important to 
engage to optimise HIV outcomes for themselves, their 
pregnant or lactating partners, and their babies, because 
incident maternal infection during breastfeeding is the 
largest contributor to postpartum mother-to-child 
transmission of HIV.2,3
In this issue of The Lancet Global Health, Wilbroad 
Mutale and colleagues report on parallel two-group 
trials in women who were HIV positive (trial 1) and 
women who were HIV negative (trial 2), all of whom 
were enrolled for antenatal care at a health facility in 
Zambia.4 In each trial, both groups received partner 
notification services according to local guidelines for 
HIV positive individuals, with adaptation for the women 
who were HIV negative. Women randomly assigned to 
the intervention were additionally offered up to five HIV 
self-tests for distribution to their partners. The primary 
outcome was male partner testing at a health facility 
within 30 days of randomisation, which was deemed 
to be important for linking men to HIV prevention and 
care, and this was measured indirectly through self-
reports by enrolled women. The primary outcome might 
have limited applicability in the era of differentiated 
services, in which the uptake of testing and linkage to 
post-test services sometimes occurs outside of health 
facilities. A more applicable predefined endpoint, which 
included the use of self-tests, was reported male partner 
testing of any kind within 30 days of randomisation.
Trial 1 recruited 116 participants and trial 2 recruited 
210 participants. The combined intervention was 
associated with lower uptake of male partner testing at 
a health facility. Of the women who were HIV positive in 
the intervention group (trial 1), 3 (6%) of 47 reported 
facility-based male partner testing versus 15 (28%) 
of 53 in the control group (probability difference 
–21·9% [95% CI –35·9 to –7·9%]). The respective results 
from trial 2 were 3 (3%) of 102 versus 33 (34%) of 98 
(probability difference –30·7% [95% CI –40·6 to –20·8]). 
However, and perhaps more importantly, reported male 
partner testing of any kind increased, with 36 (77%) of 
47 versus 19 (36%) of 53 (probability difference 40·7% 
[95% CI 23·0 to 58·4%]) in trial 1, and 80 (78%) of 102 
versus 54 (55%) of 98 (probability difference 23·3% 
[95% CI 10·7 to 36·0%]) in trial 2; probably reflecting 
self-testing in male partners. These findings add to the 
evidence of the effectiveness of secondary distribution 
of HIV self-tests in increasing uptake of testing of male 
partners of pregnant women.5
It is unsurprising that the combined intervention 
of partner notification and HIV self-test distribution 
resulted in decreased facility-based testing. HIV self-
testing is a convenient approach that allows users to 
test when and where they please. Men often avoid 
health facilities,6 hence a non-facility-based testing 
approach would probably be more acceptable. Mutale 
and colleagues worry that the decrease in facility-based 
testing could be a sign of suboptimal linkage to post-
test services. However, a 30-day window might be 
too short to estimate linkage:7 there is evidence that 
community-based HIV self-testing is associated with 
improved uptake of HIV treatment in nearby health 
facilities.8 A 2021 systematic review found that HIV 
self-testing is associated with a larger number of people 
who test and are linked to care than standard provider-
delivered testing.9
Linkage to prevention in those self-testing negative 
and at high HIV risk is a different and key consideration, 
particularly given the high rates of serodiscordancy 
that were reported by Mutale and colleagues. There 
is a dearth of trial evidence on linkage to prevention 
following HIV self-testing.9 Given our understanding of 
male aversion to visiting health facilities, the provision 
of differentiated or decentralised services such as 
community-based or work place models, which have 
successfully increased uptake of prevention services in 
men,10 could be an option for people using self-tests 
away from health facilities. However, it is important to 
determine whether these decentralised services would 
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be cost-effective, given that they can be highly resource-
intensive.11
In summary, Mutale and colleagues found that 
a combination approach that included secondary 
distribution of HIV self-tests to partners of pregnant 
women was associated with decreased uptake of facility-
based HIV testing and increased uptake of testing of any 
kind. Given the growing evidence of the effectiveness 
of secondary distribution of HIV self-tests, programmes 
need to consider including them into the mixed bag 
of combination approaches that can have positive 
effects. Self-testing has been shown to be a particularly 
acceptable and useful approach during the COVID-19 
pandemic, reducing health facility congestion and risk of 
COVID-19 in health care staff. Importantly, programmes 
need to pay attention to the potential for decreased 
linkage to post-test services, particularly prevention 
services, and explore ways of providing access to 
prevention and care in models that are acceptable to 
men. The requirement for men and other hard-to-reach 
populations to continue accessing services at health 
facilities remains a bottleneck within HIV prevention 
and treatment cascades.
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